|
| |
Image Results
Loading...
Loading...
Immunogen News Pages on BioPortfolio:
|
BioPortfolio - Hyperphar International B.V. - Profile
17 Nov 2009 ... ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference. News-Medical.Net: Nov 10 2009 12:53PM Matching: ...
http://www.bioportfolio.com/biocorporate/24210-Hyperphar%2BI...
|
Biotechnology News immunogen. tap. amgen. payload. maytansinoid ...
25 Nov 2009 ... BioNews. Biotechnology, Pharmaceutical and Life Science News ... Current Search: immunogen: 721, tap: 804, amgen: 1674, payload: 124, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio News: Reportlinker - Reportlinker Adds Monoclonal...
26 Oct 2009 ... ImmunoGen. KaloBios Pharmaceuticals. PDL BioPharma .... Browse other news from this organisation: Reportlinker. Source PR Newswire ...
http://www.bioportfolio.com/news/Reportlinker-Adds-Monoclona...
|
Biotechnology News Search
Medical News: ImmunoGen, Inc. Announces Encouraging Clinical Data With Its IMGN901 Compound In The Treatment Of Merkel Cell Carcinoma ...
http://www.bioportfolio.co.uk/Biotechnology_News_from_BioFin...
|
BioPortfolio - United Biomedical Inc - Profile
Medical News: Entest BioMedical, Inc. Sees Substantial Opportunities In Treatment ... 6811782- Peptide composition as immunogen for the treatment of
allergy ...
http://www.bioportfolio.com/biocorporate/10466-United+Biomed...
|
Biotechnology News ovarian cancer Search
Health: Terra med Alliance News FDA Approved Leukemia Drugs Shows Promise ... ImmunoGen, Inc. Announces Encouraging Clinical Data With Its IMGN901 Compound
...
http://www.bioportfolio.co.uk/ovarian%20cancer-news.htm...
|
BioPortfolio News: - ThromboGenics and BioInvent Complete...
The scope and strength of this platform is also utilised by partners, such as ALK-Abello, Bayer HealthCare, ImmunoGen, Mitsubishi Tanabe Pharma Corporation,
...
http://www.bioportfolio.com/news/ThromboGenics-and-BioInvent...
| Results from other life science and pharmaceutical sites:
BioSpace - ImmunoGen, Inc. News, Search Jobs, Events
ImmunoGen, Inc. (IMGN) Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders 11/11/2009
...
http://www.biospace.com/company_profile.aspx?CompanyId=2226...
|
ImmunoGen, Inc. - Google Finance
Get the latest on ImmunoGen, Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:IMGN...
|
News: ImmunoGen Obtains $4M Milestone from Sanofi-Aventis for ...
28 Oct 2008 ... ImmunoGen received a $4 million milestone payment with sanofi-aventis' initiation of a Phase II trial with AVE1642, an anticancer compound.
http://www.genengnews.com/news/bnitem.aspx?name=44337437...
|
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP ...
24 Nov 2009 ... (BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN - News), a biopharmaceutical company that develops targeted anticancer therapeutics, ...
http://biz.yahoo.com/bw/091124/20091124005544.html?.v=1...
|
News: ImmunoGen, Inc. Announces Election of Howard Pien to its ...
11 Nov 2009 ... ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, announced that Howard Pien was elected ...
http://www.genengnews.com/news/bnitem.aspx?name=68186867...
|
ImmunoGen, Inc. Signs Lease for Waltham Building - News, Search ...
24 Aug 2007 ... ImmunoGen (Nasdaq:IMGN - News) was represented in the lease by T3 Advisors LLC and the landlord, Intercontinental Real Estate, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=67596...
|
News: ImmunoGen, Inc. Announces Encouraging Clinical Data with Its ...
ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with
...
http://www.genengnews.com/news/bnitem.aspx?name=68761686...
|
ImmunoGen, Inc. Names New CEO - News, Search Jobs, Events
6 Jan 2009 ... Immunogen Inc., the Waltham-based biotechnology company, announced the departure of CEO Mitchell Sayare and the installment of Daniel Junius ...
http://www.biospace.com/news_story.aspx?NewsEntityId=121843...
|
News: Amgen to Apply ImmunoGen TAP Technology to Another Cancer ...
20 Nov 2009 ... Amgen licensed the exclusive right to use ImmunoGen's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer ...
http://www.genengnews.com/news/bnitem.aspx?name=69043975&tax...
|
ImmunoGen, Inc. to End Stomach-Cancer Drug Development - News ...
15 Jun 2009 ... Reuters -- Drugmaker ImmunoGen Inc said it was discontinuing further internal development of its experimental gastric-cancer drug, IMGN242, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=145365...
|
|
